Therapies for obesity and cardiovascular disease risk reduction include lifestyle, medication, and surgical interventions
Ozempic persistently accounted for most of the prescriptions, but prescription fills for Wegovy soared by more than 1,361% between July 2021 and December 2023
The overlapping GI side effect profiles mean some users experience slightly worse tolerability than with plain tirzepatide
Resources like the guide on switching between GLP-1 medications and understanding whether GLP-1 medications can be combined provide additional context for patients navigating treatment transitions
Liu S, Wang ZF, Su YS, Ray RS, Jing XH, Wang YQ, et al
Never throw loose needles into household trash